Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Pharmacology
Subjects:	Wnt signaling triple-negative breast cancer β-catenin cancer survival medicinal chemistry structure activity relationship
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1173490/full

Internet